CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities
Net loss	$ (7,730,235)	$ (11,733,549)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expense	17,003	17,004
(Gain) loss on debt extinguishment	(2,434,661)	2,268,373
Decrease in fair value of derivative liabilities	(4,145)	(67,439)
Amortization of discount on notes payable	3,074,198	3,242,080
Accrued interest on patents purchased	123,233	258,246
Amortization of patents and acquired contracts	1,623,980	1,643,110
Net cost of patents sold	0	215,373
Stock-based compensation	566,677	1,147,374
Changes in operating assets and liabilities
Accounts receivable	11,123	227,108
Inventories	0	302,739
Prepaid expenses and other current assets, net	(732,480)	1,192
Deferred expenses	(19,117)	(78,292)
Deposits and other assets	0	0
Accounts payable	(88,273)	344,965
Accrued expenses and other current liabilities	159,715	(288,406)
Deferred revenue	350,000	896,429
Net cash used in operating activities	(5,082,982)	(1,603,693)
Cash flows from financing activities
Proceeds from issuance of preferred stock, net of issuance costs	5,221,997	0
Proceeds from issuance of common stock, net of issuance costs	6,310,619	1,835,000
Proceeds from issuance of notes payable	0	1,126,900
Payments on Senior notes payable	(1,640,016)	(2,147,000)
Redemption of preferred stock	(3,837,400)	0
Payments on related party note payable	(50,000)	(100,000)
Net cash provided by financing activities	6,005,200	714,900
Net increase (decrease) in cash and cash equivalents	922,218	(888,793)
Cash and cash equivalents, beginning of period	554,556	1,443,349
Cash and cash equivalents, end of period	1,476,774	554,556
Supplemental disclosures of cash flow information
Cash paid for interest	553,995	841,784
Supplemental disclosures of non-cash investing and financing activities
Accrued guaranteed payments and deferred expenses related to purchased patents	0	(16,258,540)
Conversion of portion of short term note payable, related party, to purchase common stock	0	100,000
Conversion of preferred stock to common stock	0	2,711
Fair value of common stock warrants	6,315,220	41,305
Cancelation of short-term note payable, related party	$ 50,000	$ 0